Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Imam Khomeini Hospital, Tehran, Iran, Islamic Republic of
Fundación Universitaria de Ciencias de la Salud, Bogota, Colombia
Baystate Medical Center, Springfield, Massachusetts, United States
Mission Hospital, Asheville, North Carolina, United States
Baton Rouge General Medical Center and Our Lady of The Lakes Regional Medical Center, Baton Rouge, Louisiana, United States
Tianjin Medical University, Tianjin, China
University of California, Irvine, Irvine, California, United States
NKC Institues of Gastroenterology and Hepatology, Prince of Songkla University, Hatyai, Songkhla, Thailand
XiangYa Hospital, Central South University, Changsha, Hunan, China
Nationwide Children's Hospital, Columbus, Ohio, United States
Department of Anesthesiology and Pain Medicine, Gwangju, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.